| 股票 | 申万二级 | PE | 前瞻PE | PEG | PB | 股息率 | 分红率 | 毛利率 | 固定资产 | 债/EBITDA | FCF/市值 | 营收3年 | 去年 | YTD | 近一年 | 回撤 | 波动 | 市值亿 ▾ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 华润三九 000999 | 中药Ⅱ | 12.6 | 11.4 | 1.04 | 1.81 | 4.2% | 50% | 54% | 19% | 0.7 | 9.0% | +20% | -15% | -11% | -17% | -26% | 21% | 414 |
| 济川药业 600566 | 中药Ⅱ | 12.9 | 13.1 | 1.64 | 1.72 | 6.7% | 76% | 82% | 14% | 0.7 | 3.4% | -12% | -3% | +5% | +4% | -18% | 29% | 237 |
| 华润江中 600750 | 中药Ⅱ | 17.0 | 15.3 | 1.39 | 3.76 | 5.9% | 96% | 65% | 29% | 0.0 | 5.0% | +3% | +8% | +5% | +12% | -19% | 28% | 149 |
| 奇正藏药 002287 | 中药Ⅱ | 17.2 | — | — | 2.23 | 3.1% | 53% | 84% | 25% | 1.1 | 2.8% | +6% | +15% | -14% | -31% | -34% | 24% | 114 |
| 羚锐制药 600285 | 中药Ⅱ | 14.3 | 13.2 | 1.10 | 3.44 | 5.6% | 79% | 74% | 12% | 0.4 | 7.8% | +9% | -3% | +0% | -13% | -17% | 23% | 111 |
| 三力制药 603439 | 中药Ⅱ | 13198.2 | — | — | 3.37 | 0.5% | 51% | 70% | 18% | 2.8 | 4.6% | +12% | -8% | +5% | -6% | -43% | 38% | 49 |
点表头排序。市值单位亿元;去年/YTD 为前复权涨幅;债/EBITDA = 有息负债 ÷ EBITDA。